Login
CanSaRCC
Canadian Sarcoma Research and
Clinical Collaboration
Menu
Overview
MemorialWall
About CanSaRCC
Team
Donate
Clinical Trials
Member Directory
Register
Login
Clinical Trials
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
Link
:
https://clinicaltrials.gov/ct2/show/NCT03967223
Status
:
CLOSED
Population
: Synovial Sarcoma
Description
: ACT in SS
PI
: A. Razak
J. Noujaim
Centers Opened
: PMH
HMR
Phase
: II
IIST/Pharma
: Pharma